About
'Ms. Gregory's deep knowledge and connections across the global pharmaceutical landscape will be critical in furthering Devonian's stated strategy to advance our clinical programs and plans for future commercialization and partnership', said
'We are thrilled that someone of Kathryn's caliber is joining our board, bringing along her exceptional strategic and governance skills and experience. I look forward to working closely with her and drawing on her extensive biopharma experience,' added
Grant of Stock Options
The Corporation also announced that the Board has approved the granting of 50,000 stock options to a director of the Corporation, allowing the option holder to acquire subordinate voting shares of the Corporation at an exercise price of
About Devonian
Devonian is also involved in the development of high-value cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings.
Cautionary Note Regarding Forward-Looking Statements
All statements, other than statements of historical fact, contained in this press release including, but not limited to those relating to the approval of the Exchange regarding the option grant, and generally the above 'About Devonian' paragraph, which essentially describe the Corporation's outlook, constitute 'forward-looking information' or 'forward-looking statements' within the meaning of certain securities laws, and are based on expectations, estimates and projections as of the time of this press release
Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Corporation as of the time of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. These estimates and assumptions may prove to be incorrect. Many of these uncertainties and contingencies can directly or indirectly affect, and could cause, actual results to differ materially from those expressed or implied in any forward-looking statements. There can be no assurance that these assumptions will prove to be correct and there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that estimates, forecasts, projections and other forward-looking statements will not be achieved or that assumptions do not reflect future experience. Forward-looking statements are provided for the purpose of providing information about management's expectations and plans relating to the future. Readers are cautioned not to place undue reliance on these forward-looking statements as a number of important risk factors and future events could cause the actual outcomes to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates, assumptions and intentions expressed in such forward-looking statements. All of the forward-looking statements made in this press release are qualified by these cautionary statements and those made in our other filings with the applicable securities regulators of
Contact:
Mr.
Tel: 1 (450) 979-0598
Email: investors@groupedevonian.com
(C) 2024 Electronic News Publishing, source